Preconditioning but not postconditioning treatment with resveratrol substantially ameliorates post‑resuscitation myocardial dysfunction through the PI3K/Akt signaling pathway

Zhang,Haihong; Wu,Qinqin; Wan,Zhi; Cao,Yu; Zeng,Zhi

doi:10.3892/mmr.2019.10318

Preconditioning but not postconditioning treatment with resveratrol substantially ameliorates post‑resuscitation myocardial dysfunction through the PI3K/Akt signaling pathway

Authors:
- Haihong Zhang
- Qinqin Wu
- Zhi Wan
- Yu Cao
- Zhi Zeng
View Affiliations

Affiliations: Emergency Department, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: May 31, 2019 https://doi.org/10.3892/mmr.2019.10318
Pages: 1250-1258
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Post‑resuscitation myocardial dysfunction (PRMD) is a severe complication that arises in patients after cardiac arrest (CA). However, there are no safe or effective treatment strategies that are currently available to treat these patients. In the present study, it was investigated whether resveratrol administration could inhibit myocardial nitrative stress to alleviate PRMD. CA was induced in Sprague‑Dawley rats by trans‑oesophageal alternating electrical stimulation, followed by cardiopulmonary resuscitation. Rats were then randomly divided into a preconditioning or a postconditioning group. Left ventricular function (+dP/dtmax and ‑dP/dtmin) was recorded for 4 h after the return of spontaneous circulation (ROSC), after which the animals were euthanized. Myocardial nitrative stress was analysed using enzyme‑linked immunosorbent assay, western blotting and immunohistochemistry. Wortmannin (a PI3K inhibitor) was used to investigate the involvement of the PI3k/Akt signalling pathway in the cardio‑protective activity of resveratrol. After ROSC, resveratrol improved PRMD compared to the vehicle control; however, resveratrol administration significantly improved PRMD in the preconditioning group compared to the postconditioning group. Likewise, resveratrol preconditioning significantly decreased the expression of iNOS and nitrotyrosine in rat hearts but did not significantly ameliorate myocardial nitrative stress. Wortmannin partially inhibited the protective effect of resveratrol preconditioning and resulted in the deterioration of cardiac function and increase in iNOS and nitrotyrosine levels. Resveratrol preconditioning could alleviate PRMD by inhibiting myocardial nitrative stress. The PI3K/Akt signalling pathway may be partially involved in the process.

View Figures

View References

1	Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS, Zhou HL, Gou ZP, Zhao LC, Niu HX, Chen KP, et al: Incidence of sudden cardiac death in China: Analysis of 4 regional populations. J Am Coll Cardiol. 54:1110–1118. 2009. View Article : Google Scholar : PubMed/NCBI
2	Langhelle A, Tyvold SS, Lexow K, Hapnes SA, Sunde K and Steen PA: In-hospital factors associated with improved outcome after out-of-hospital cardiac arrest. A comparison between four regions in Norway. Resuscitation. 56:247–263. 2003. View Article : Google Scholar : PubMed/NCBI
3	Granfeldt A: Organ dysfunction following regional and global ischemia/reperfusion. Intervention with postconditioning and adenocaine. Dan Med J. 59:B44962012.PubMed/NCBI
4	Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P, Spaulding C, et al: Successful cardiopulmonary resuscitation after cardiac arrest as a ‘sepsis-like’ syndrome. Circulation. 106:562–568. 2002. View Article : Google Scholar : PubMed/NCBI
5	Han F, Da T, Riobo NA and Becker LB: Early mitochondrial dysfunction in electron transfer activity and reactive oxygen species generation after cardiac arrest. Crit Care Med 36 (11 Suppl). S447–S453. 2008. View Article : Google Scholar
6	Brookes P and Darley-Usmar VM: Hypothesis: The mitochondrial NO (*) signaling pathway, and the transduction of nitrosative to oxidative cell signals: An alternative function for cytochrome C oxidase. Free Radic Biol Med. 32:370–374. 2002. View Article : Google Scholar : PubMed/NCBI
7	Ischiropoulos H and Beckman JS: Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J Clin Invest. 111:163–169. 2003. View Article : Google Scholar : PubMed/NCBI
8	Rossig L, Haendeler J, Hermann C, Malchow P, Urbich C, Zeiher AM and Dimmeler S: Nitric oxide down-regulates MKP-3 mRNA levels: Involvement in endothelial cell protection from apoptosis. J Biol Chem. 275:25502–25507. 2000. View Article : Google Scholar : PubMed/NCBI
9	Kim YM, Bombeck CA and Billiar TR: Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 84:253–256. 1999. View Article : Google Scholar : PubMed/NCBI
10	Jiao XY, Gao E, Yuan Y, Wang Y, Lau WB, Koch W, Ma XL and Tao L: INO-4885 [5,10,15,20-tetra[N-(benzyl-4′- carboxylate)- 2-pyridinium]-21H,23H-porphine iron(III) chloride], a peroxynitrite decomposition catalyst, protects the heart against reperfusion injury in mice. J Pharmacol Exp Ther. 328:777–784. 2009. View Article : Google Scholar : PubMed/NCBI
11	Arstall MA, Sawyer DB, Fukazawa R and Kelly RA: Cytokine-mediated apoptosis in cardiac myocytes: The role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res. 85:829–840. 1999. View Article : Google Scholar : PubMed/NCBI
12	Hung LM, Chen JK, Huang SS, Lee RS and Su MJ: Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res. 47:549–555. 2000. View Article : Google Scholar : PubMed/NCBI
13	Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, Sharifi-Azad S, Grunwald Z, Ma XL and Sun JZ: Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J Surg Res. 131:64–72. 2006. View Article : Google Scholar : PubMed/NCBI
14	Mokni M, Limam F, Elkahoui S, Amri M and Aouani E: Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch Biochem Biophys. 457:1–6. 2007. View Article : Google Scholar : PubMed/NCBI
15	Shen M, Jia GL, Wang YM and Ma H: Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats. Vascul Pharmacol. 45:122–126. 2006. View Article : Google Scholar : PubMed/NCBI
16	Goh SS, Woodman OL, Pepe S, Cao AH, Qin C and Ritchie RH: The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid Redox Signal. 9:101–113. 2007. View Article : Google Scholar : PubMed/NCBI
17	Hassan-Khabbar S, Cottart CH, Wendum D, Vibert F, Clot JP, Savouret JF, Conti M and Nivet-Antoine V: Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: A possible strategy in liver surgery. Liver Transpl. 14:451–459. 2008. View Article : Google Scholar : PubMed/NCBI
18	Gurusamy N, Lekli I, Mukherjee S, Ray D, Ahsan MK, Gherghiceanu M, Popescu LM and Das DK: Cardioprotection by resveratrol: A novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res. 86:103–112. 2010. View Article : Google Scholar : PubMed/NCBI
19	Chen MH, Liu TW, Xie L, Song FQ, He T, Mo SR and Zeng ZY: A simpler cardiac arrest model in the mouse. Resuscitation. 75:372–379. 2007. View Article : Google Scholar : PubMed/NCBI
20	Yin XL, Zhang W, Yang Y and Shen H: Increasing expression of (CCAAT enhancer binding protein) homologous protein induced by endoplasmic reticulum stress in myocardium after cardiac arrest and resuscitation in rat. Resuscitation. 83:378–385. 2012. View Article : Google Scholar : PubMed/NCBI
21	Knapp J, Bergmann G, Bruckner T, Russ N, Bottiger BW and Popp E: Pre- and postconditioning effect of sevoflurane on myocardial dysfunction after cardiopulmonary resuscitation in rats. Resuscitation. 84:1450–1455. 2013. View Article : Google Scholar : PubMed/NCBI
22	Mukherjee S, Dudley JI and Das DK: Dose-dependency of resveratrol in providing health benefits. Dose Response. 8:478–500. 2010. View Article : Google Scholar : PubMed/NCBI
23	Shen M, Wu RX, Zhao L, Li J, Guo HT, Fan R, Cui Y, Wang YM, Yue SQ and Pei JM: Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism. PLoS One. 7:e512232012. View Article : Google Scholar : PubMed/NCBI
24	Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, et al: Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 16:1246–1252. 2007. View Article : Google Scholar : PubMed/NCBI
25	Juan SH, Cheng TH, Lin HC, Chu YL and Lee WS: Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochem Pharmacol. 69:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
26	Safar P: Effects of the postresuscitation syndrome on cerebral recovery from cardiac arrest. Crit Care Med. 13:932–935. 1985. View Article : Google Scholar : PubMed/NCBI
27	Senthil M, Brown M, Xu DZ, Lu Q, Feketeova E and Deitch EA: Gut-lymph hypothesis of systemic inflammatory response syndrome/multiple-organ dysfunction syndrome: Validating studies in a porcine model. J Trauma. 60:958–967. 2006. View Article : Google Scholar : PubMed/NCBI
28	Rubertsson S, Grenvik A and Wiklund L: Blood flow and perfusion pressure during open-chest versus closed-chest cardiopulmonary resuscitation in pigs. Crit Care Med. 23:715–725. 1995. View Article : Google Scholar : PubMed/NCBI
29	Bradamante S, Barenghi L, Piccinini F, Bertelli AA, De Jonge R, Beemster P and De Jong JW: Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine- mediated mechanism. Eur J Pharmacol. 465:115–123. 2003. View Article : Google Scholar : PubMed/NCBI
30	Wu D, Bassuk J, Arias J, Kurlansky P, Lozano H, Lamas G and Adams JA: Different roles of nitric oxide synthase isoforms in cardiopulmonary resuscitation in pigs. Resuscitation. 73:144–153. 2007. View Article : Google Scholar : PubMed/NCBI
31	Hung LM, Su MJ and Chen JK: Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med. 36:774–781. 2004. View Article : Google Scholar : PubMed/NCBI
32	Zhang HX, Duan GL, Wang CN, Zhang YQ, Zhu XY and Liu YJ: Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress. Pulm Pharmacol Ther. 27:150–155. 2014. View Article : Google Scholar : PubMed/NCBI
33	Hsieh TC, Juan G, Darzynkiewicz Z and Wu JM: Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59:2596–2601. 1999.PubMed/NCBI
34	Wang A, Liu M, Liu X, Dong LQ, Glickman RD, Slaga TJ, Zhou Z and Liu F: Up-regulation of adiponectin by resveratrol: The essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J Biol Chem. 286:60–66. 2011. View Article : Google Scholar : PubMed/NCBI
35	Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang L, Zheng Q, Zhang H and Gao F: Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab. 298:E871–E880. 2010. View Article : Google Scholar : PubMed/NCBI
36	Wang WQ, Zhang HF, Gao GX, Bai QX, Li R and Wang XM: Adiponectin inhibits hyperlipidemia-induced platelet aggregation via attenuating oxidative/nitrative stress. Physiol Res. 60:347–354. 2011.PubMed/NCBI
37	Huang T, Gao D, Jiang X, Hu S, Zhang L and Fei Z: Resveratrol inhibits oxygen-glucose deprivation-induced MMP-3 expression and cell apoptosis in primary cortical cells via the NF-kappaB pathway. Mol Med Rep. 10:1065–1071. 2014. View Article : Google Scholar : PubMed/NCBI
38	Zhang H, Morgan B, Potter BJ, Ma L, Dellsperger KC, Ungvari Z and Zhang C: Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: In vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol. 299:H985–H994. 2010. View Article : Google Scholar : PubMed/NCBI